Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Carlson

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
The American Journal of Gastroenterology|April 2, 2004
Success and shortcomings of a clinical care pathway in the management of acute nonvariceal upper gastrointestinal bleedingPatrick R Pfau, Gregory S Cooper, Mark D Carlson, et al.
Circulation|January 20, 2005
Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm SocietyBradley P Knight, Bernard J Gersh, Mark D Carlson, et al.
Journal of the American College of Cardiology|August 23, 2003
A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT)Mark D Carlson, John Ip, John Messenger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 19, 2025
Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace)Reinhard C Funck, Hans-Helge Müller, Maurizio Lunati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancerStephanie L Hines, Betty Anne Mincey, Jeff A Sloan, et al.
The Journal of Supportive Oncology|June 28, 2011
A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CACharles L Loprinzi, Ernie P Balcueva, Heshan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5Charles L Loprinzi, John W Kugler, Debra L Barton, et al.
American Heart Journal|August 13, 2011
Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practiceZubin J Eapen, Eric D Peterson, Gregg C Fonarow, et al.
Circulation|November 18, 2009
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trialDouglas L Packer, Jordan M Prutkin, Anne S Hellkamp, et al.
American Heart Journal|October 12, 2010
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapiesMelissa H Kong, Eric D Peterson, Gregg C Fonarow, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
The American Journal of Gastroenterology|April 2, 2004
Success and shortcomings of a clinical care pathway in the management of acute nonvariceal upper gastrointestinal bleedingPatrick R Pfau, Gregory S Cooper, Mark D Carlson, et al.
Circulation|January 20, 2005
Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm SocietyBradley P Knight, Bernard J Gersh, Mark D Carlson, et al.
Journal of the American College of Cardiology|August 23, 2003
A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT)Mark D Carlson, John Ip, John Messenger, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 19, 2025
Biventricular vs. right ventricular pacing devices in patients anticipated to require frequent ventricular pacing (BioPace)Reinhard C Funck, Hans-Helge Müller, Maurizio Lunati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2008
Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancerStephanie L Hines, Betty Anne Mincey, Jeff A Sloan, et al.
The Journal of Supportive Oncology|June 28, 2011
A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CACharles L Loprinzi, Ernie P Balcueva, Heshan Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2006
Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5Charles L Loprinzi, John W Kugler, Debra L Barton, et al.
American Heart Journal|August 13, 2011
Quality of care for sudden cardiac arrest: Proposed steps to improve the translation of evidence into practiceZubin J Eapen, Eric D Peterson, Gregg C Fonarow, et al.
Circulation|November 18, 2009
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trialDouglas L Packer, Jordan M Prutkin, Anne S Hellkamp, et al.
American Heart Journal|October 12, 2010
Addressing disparities in sudden cardiac arrest care and the underutilization of effective therapiesMelissa H Kong, Eric D Peterson, Gregg C Fonarow, et al.
Pageof 3